Chief of Party, Impact Malaria (PMI) DRC Chez Medical Care Development International-MCDI, Kinshasa, Democratic Republic of the CongoDemocratic Republic of the Congo
M&E Officer, PMI Impact Malaria, DRC Technical Diagnostics, Democratic Republic of the CongoDemocratic Republic of the Congo
Also available as PDF (figures and tables appear in the PDF).
Malaria is endemic to many African countries and geographies and remains the leading cause of morbidity and mortality on the continent. Ongoing efforts by health authorities to reverse the scale of malaria are often faced to the challenges of drug resistance often generated by therapeutic abuses relating to self-medication, sub-therapeutic under dosages and poor storage and handling of drugs throughout the pharmacy supply chain system.
Keywords: Malaria; Covid-19; Morbidity and mortality; Abuse antimalarial; Drug resistance
The precarious context of health systems of developing countries will surely influence the intensification of the spread of CO- VID-19, because of low awareness of preventive measures among the population. On the other hand, the incorrect or reckless use of anti-malaria molecules in the management of COVID-19 will lead to new resistance to these drugs, with increased rates of morbidity and mortality from malaria. And a greater than ever resulting need for a newer, more expensive but perhaps more durable antimalarial to be developed.
Research on therapeutic efficacy of antimalarial drugs stopcoronavirusrdc.info/. Accessed July 29, 2020.
2. Drug resistance and response. Web site. https://www.who.int/ malaria/areas/drug_resistance/en/. Accessed July 29, 2020.
3. Google Scholar. Web site. https://scholar.google.com/scholar ?q=DRC+Demographic+and+Health+Survey,+DHS+2004&h l=en&as_sdt=0&as_vis=1&oi=scholart. Accessed July 29, 2020.
4. Annales Africanies de Medecine. Web site. https://anafrimed. net/quel-systeme-de-securite-sociale-pour-la-rdc-assurance-maladie-mutuelles-assurances-privees/. Accessed July 29, 2020.